AzTrials
AzTrials

Immunization; InfectionNCT03379467

Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage

A study testing SMS Reminder and Interactive Reminder in people with Immunization; Infection and SMS, run by Interactive Research and Development.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies before their fifth birthday. In part, this is due to the low coverage rate of routine childhood immunizations. Read more about this study

Who is it for?
Ages 6 to 12 weeksHealthy volunteers can take part
Conditions the study is for
Immunization; Infection, SMS
What is being tested?
SMS Reminder and Interactive Reminder
Type of treatment
Vaccines
Could I receive a placebo?
No, everyone receives an active treatment
How many people
655 participants
Where
No sites listed yet
Study dates
23 May 2011to 8 Mar 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 weeks
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Child presenting for pentavalent 1- vaccine
  • Caregivers who owned a cellphone or had access to one
  • Caregivers permanently residing in Korangi Town, Karachi

Who cannot join

  • Child presenting for a vaccine other than pentavalent -1
  • Caregivers not having access to a cell phone
  • Caregivers residing outside of Korangi or planning to move from the catchment area

About this study

Official title: Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage: A Randomized Controlled Trial

Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies before their fifth birthday. In part, this is due to the low coverage rate of routine childhood immunizations. Since Pakistan is a Low Middle Income Country (LMIC) it is essential that an immunization intervention be developed that is suitable for its socioeconomic setting. The tele-density of Pakistan exceeds 70% and the cost of SMS in Pakistan is very low. Moreover the use of SMS in the country has broadened beyond the conventional use of peer-peer chat to include social networking, SMS banking, delivery tracking, advertising, business, disaster management, and identity verification. This study will utilise this prevalence of mobile phones to assess whether simple and interactive sms reminders can serve to increase childhood immunization coverage and timeliness.

The pilot study will be carried out only in 2 EPI (Extended program on Immunization) centers at Korangi. The pilot will determine whether automated text messages produce increased immunization coverage in the reminder groups compared to the control group. 656 participants will be enrolled at Penta-1 and will be followed up until measles-2 vaccination. The results of proposed pilot will provide the basis for a large scale-up study in urban and rural settings in Pakistan.

Read the detailed description

Hypothesis:

The coverage rate of Penta-3, Measles-1 and Measles-2 in infants in Karachi will improve with:

  1. Short text Messaging Service (SMS) reminders
  2. Interactive reminders

Aims:

  1. To determine if SMS reminders increases timely vaccine coverage rate in infants from Karachi.
  2. To determine if Interactive reminders increases the timely vaccine coverage rate in infants from Karachi.

Background and Rationale:

The World Health Organization's (WHO) goal is to protect all people at risk against vaccine-preventable diseases. The availability of vaccines, however, does not mean that all eligible children are vaccinated. Despite several decades of global efforts in program implementation, vaccine-preventable diseases still contribute 25% of the 10 million deaths/year in under-5 children occurring worldwide. The Expanded Program on Immunization (EPI) does provide wide-access to vaccines in developing countries, but low vaccine uptake and delayed immunizations make infants and children more vulnerable to vaccine preventable diseases. The result of suboptimal immunization rates is the persistent existence of several vaccine preventable diseases. Many different strategies are being tested in these settings to increase immunization coverage, including out-reach services, health education, information dissemination, vaccination requirements for schools, conditional cash transfers and enhancing access to vaccination centers. This study proposes to investigate the use of SMS and interactive text reminders to improve timely immunization coverage. SMS reminders have the potential to increase immunization coverage and could prove to be a simple low cost intervention to improve timely immunization coverage.

SMS reminders Although there is limited data, SMS has been successfully used in various health programs including raising preventive and clinical treatment compliance, increasing HIV testing,4 reducing missed primary care and dental visits etc. Kaewkungwal's study designed a maternal and child care module based on SMS reminders and increased EPI on-time vaccinations to 44% from 35% (p<0.001). Vilella's study showed 47% (95% Confidence Interval (CI): 41-54%) of the participants in SMS reminder intervention arm completed third dose of hepatitis A + B vaccine as compared to 27% (95% CI: 23-32%) in control arm (RR 1.75; 95% CI: 1.41-2.17). SMS reminders have shown a potential simple cost-effective solution to remember the next vaccination date. With the growing use of mobile phones, SMS reminders can be quite useful in health communications. The cost of SMS in Pakistan is very low and use of SMS has broadened beyond the conventional use of peer-peer chat to include social networking, SMS banking, delivery tracking, advertising, business, disaster management, and identity verification etc. With such a low cost and varied use of SMS, it has a potential to be a frequent mode of health communications.

Interactive reminders Interactive reminders are a variant of SMS reminders where recipients are asked to respond back to SMS with a specific/non-specific response. Our experience of pilot with interactive reminders to tuberculosis patients to comply with drug adherence has shown positive acceptability. The system can be potentially used for compliance to vaccine schedule. The pilot study will be carried out only in 2 EPI centers at Korangi. The pilot will determine whether automated text messages produce increased immunization coverage in the reminder groups compared to the control group over the 8 weeks follow-up. The results of proposed pilot will provide the basis for a large scale-up study in urban and rural settings in Pakistan.

Study site \& Participants:

The study will be conducted in Korangi town, Karachi. Healthy infants 6-12 weeks of age visiting the Indus Hospital EPI center for first dose of pentavalent vaccine will be recruited for the study. Study will require parents/caregivers of infants to own a cell phone or have regular access to one. Parents/caregivers planning to go to a different center for next immunization will be excluded.

Sample size:

A sample of 522 participants would give 90% power (alpha= 0.05, 2-sided) to detect a difference of 15% over the baseline vaccine coverage rate of 70%. The final sample size of 656 infants (164 in each arm) will allow for a potential dropout rate of 20% during the follow-up period.

Randomization Enrolled subjects will be randomized to receive the SMS, interactive SMS or to serve as a control. The randomization sequence was created using SAS, version 9.3 (SAS Institute, Cary, NC), with a 1:1:1 allocation, using random block sizes of 3, 6, and 9.

Vaccines:

The vaccines will be administered as per routine EPI program in Pakistan which include Bacille Calmette-Guérin (BCG) at 0-6 weeks of age, pentavalent (DPT + Hepatitis B (HepB) + Hib) vaccine and oral polio vaccine at 6, 10 and 14 weeks of age, measles vaccine at 9 and 15 months of age.

Interventions:

The two interventions include SMS and interactive reminders. Infants will be randomized to either of the interventions or control groups. All participants will receive the routine EPI immunizations.

Study procedures \& Recruitment:

Children will be recruited at the EPI center when they arrived for the Penta-1 vaccine. Field workers will screen and obtain consent from the child's caregiver. Once the caregiver agrees to be a part of the study the infant will be randomised to one of the study arms and the name and age of the child will be recorded along with the immunization received on the visit. Each infant will be provided with a unique EPI number by the EPI staff and the same identifier (ID) will be used throughout the study to update and maintain the immunization record for all follow up visits. The child will be followed up to the measles 2 vaccine after which their immunization status will be marked as complete.

The parents of infants in SMS and interactive reminder groups will received 3-5 reminders for all scheduled follow-up immunization visits until the measles 2 vaccine. The infants in the control group will carry out routine follow up without any added intervention.

After the completion of follow-up duration a phone interview will be conducted to collect data on experiences of study participants with the SMS and interactive reminders. This will be a brief 3-5 minute interview to confirm if they received the messages and if there were any suggestions to improve the reminder system.

Statistical Analysis An intention to treat analysis will be conducted using STATA'13. Summary statistics and percentages will be calculated to establish coverage and timeliness rates within the three study arms. Fisher's Exact test with an alpha of 0.05 will be conducted to test differences in proportions for coverage and timelines

Additionally to determine factors associated with measles-2 completion at 24 months of age, a bivariate analysis will be conducted.Variables previously examined for association with measles 2 completion at 24 months via a bivariate analysis will then be selected for determining final multivariate model. All the variables will first be used in the model and the coefficients and the vif will be examined. Next, forward selection and step wise selection will be carried out in STATA to determine final model for a logistic regression.

Being tested
SMS Reminder, Interactive Reminder
Keywords
SMS Reminder, Two-way Reminder
Medical subject headings
Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SMS ReminderOther

    A text message sent as a reminder for immunization on the registered phone number

  • Interactive ReminderOther

    A text message sent as a reminder for immunization on the registered phone number which requires the receiver to respond back

Study groups in NCT03379467
Study groupRoleWhat they receive
SMS ReminderExperimentalSingle SMS at each of the following times: * 3 days before immunization * 1 day before immunization * Day of immunization
Receives: Other: SMS Reminder
Interactive ReminderExperimentalSingle SMS at each of the following times: * 3 days before immunization * 1 day before immunization * Day of immunization On the day of immunization, study participants are required to respond back through SMS notifying us that child got vaccinated or if not, the reason for delay in immunization. In case of no response, 2 additional reminders will be sent at: * 1 day after scheduled immunization date * 1 week after scheduled immunization date
Receives: Other: Interactive Reminder
ControlNo interventionSubjects in this arm will not receive any intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measles - 2 Completion

    The primary outcome for the study is the proportion of infants completing measles 2 vaccine on schedule.

    Measured: When the participants reach 2 years of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2017
  2. Study start23 May 2011
  3. Primary completion8 Mar 2014
  4. Study completion8 Mar 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is an individually randomized, three-arm parallel group design randomized control trial with equal allocation in the two treatment groups and control group. The parents of infants in SMS and interactive reminder groups will receive 3-5 reminders for scheduled follow-up immunization visits. The difference in between SMS and interactive reminders is that parents in SMS reminders are not asked to respond back to SMS reminders. The infants in control group will carry out routine follow-ups without any added intervention.
Masking
None (open label)
Enrolment
655 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03379467
Sponsor's protocol ID
IRD_IRB_2011_05_005
Status last verified
Dec 2017
First submitted
14 Dec 2017
Last updated
21 Dec 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.

    PubMed 32813276

Questions about this trial

What is this clinical trial studying?

A study testing SMS Reminder and Interactive Reminder in people with Immunization; Infection and SMS, run by Interactive Research and Development.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measles - 2 Completion (time frame: When the participants reach 2 years of age). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03379467, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in